24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
Saved in:
| Title: | 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release. |
|---|---|
| Authors: | Azar P; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Li VW; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Wong JSH; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Nikoo M; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Machado J; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada., Ignaszewski MJ; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, BC, Canada., Mathew N; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, BC, Canada., Raheemullah A; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, USA., Wakeman SE; Department of Medicine, Massachusetts General Hospital, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA., Mullen R; The C4 Foundation, Coronado, CA, USA., Krausz RM; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Montaner JSG; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada., Maharaj AR; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. |
| Source: | Journal of psychoactive drugs [J Psychoactive Drugs] 2026 Apr-Jun; Vol. 58 (2), pp. 166-170. Date of Electronic Publication: 2024 Nov 19. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8113536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-9777 (Electronic) Linking ISSN: 02791072 NLM ISO Abbreviation: J Psychoactive Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39560320 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Azar+P%22">Azar P</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Li+VW%22">Li VW</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Wong+JSH%22">Wong JSH</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Nikoo+M%22">Nikoo M</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Machado+J%22">Machado J</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ignaszewski+MJ%22">Ignaszewski MJ</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Mathew+N%22">Mathew N</searchLink>; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Raheemullah+A%22">Raheemullah A</searchLink>; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Wakeman+SE%22">Wakeman SE</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Mullen+R%22">Mullen R</searchLink>; The C4 Foundation, Coronado, CA, USA.<br /><searchLink fieldCode="AU" term="%22Krausz+RM%22">Krausz RM</searchLink>; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Montaner+JSG%22">Montaner JSG</searchLink>; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Maharaj+AR%22">Maharaj AR</searchLink>; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228113536%22">Journal of psychoactive drugs</searchLink> [J Psychoactive Drugs] 2026 Apr-Jun; Vol. 58 (2), pp. 166-170. <i>Date of Electronic Publication: </i>2024 Nov 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Case Reports – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8113536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-9777 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202791072%22">02791072 </searchLink><i>NLM ISO Abbreviation: </i>J Psychoactive Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39560320 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/02791072.2024.2430616 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 166 Titles: – TitleFull: 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Azar P – PersonEntity: Name: NameFull: Li VW – PersonEntity: Name: NameFull: Wong JSH – PersonEntity: Name: NameFull: Nikoo M – PersonEntity: Name: NameFull: Machado J – PersonEntity: Name: NameFull: Ignaszewski MJ – PersonEntity: Name: NameFull: Mathew N – PersonEntity: Name: NameFull: Raheemullah A – PersonEntity: Name: NameFull: Wakeman SE – PersonEntity: Name: NameFull: Mullen R – PersonEntity: Name: NameFull: Krausz RM – PersonEntity: Name: NameFull: Montaner JSG – PersonEntity: Name: NameFull: Maharaj AR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr-Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2159-9777 Numbering: – Type: volume Value: 58 – Type: issue Value: 2 Titles: – TitleFull: Journal of psychoactive drugs Type: main |
| ResultId | 1 |